Epigenetic deregulation of SETDB1 expression seems to be involved in various types of cancers, including melanoma [37], hepatocellular carcinoma, ovarian [41], lung cancer, colorectal [42] and breast cancer [29, 43]. This evidence concerns the gene SETDB1 and lung cancer.